{"title":"实验药物显示可减少罗格列酮的不良反应","authors":"Iskandar Idris","doi":"10.1002/doi2.00019","DOIUrl":null,"url":null,"abstract":"<p>Use of an experimental drug with Rosiglitazone shown to reduce similar degree of insulin sensitization without the known adverse effects of Rosiglitazone.</p>","PeriodicalId":100370,"journal":{"name":"Diabetes, Obesity and Metabolism Now","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/doi2.00019","citationCount":"0","resultStr":"{\"title\":\"Experimental drug shown to reduce adverse effects of Rosiglitazone\",\"authors\":\"Iskandar Idris\",\"doi\":\"10.1002/doi2.00019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Use of an experimental drug with Rosiglitazone shown to reduce similar degree of insulin sensitization without the known adverse effects of Rosiglitazone.</p>\",\"PeriodicalId\":100370,\"journal\":{\"name\":\"Diabetes, Obesity and Metabolism Now\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-08-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/doi2.00019\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity and Metabolism Now\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/doi2.00019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity and Metabolism Now","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/doi2.00019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Experimental drug shown to reduce adverse effects of Rosiglitazone
Use of an experimental drug with Rosiglitazone shown to reduce similar degree of insulin sensitization without the known adverse effects of Rosiglitazone.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
